Martin Erixon

Plus aucun poste en cours

Health Technology

Consumer Services

Process Industries

Profil

Martin Erixon formerly worked at Hamlet BioPharma AB, as Chief Executive Officer from 2022 to 2023, Hamlet BioPharma AB, as Chief Executive Officer from 2023 to 2025, Gambro AB, as Manager-Research & Development Project, and Tetra Pak AB, as Manager-Research & Development Project from 2011 to 2022.
Mr. Erixon received his doctorate degree in 2007 from the University of Lund.

Anciens postes connus de Martin Erixon

Sociétés	Poste	Fin
HAMLET PHARMA AB (PUBL)	Directeur Général	18/02/2025
HAMLET PHARMA AB (PUBL)	Directeur Général	01/10/2023
Tetra Pak AB Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products	Corporate Officer/Principal	01/06/2022
Gambro AB Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products	Corporate Officer/Principal	-

Voir l'expérience en détail de Martin Erixon

Formation de Martin Erixon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Martin Erixon

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Gambro AB Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products	Health Technology
University of Lund University of Lund Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tetra Pak AB Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products	Process Industries
Hamlet BioPharma AB Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients	Health Technology